7 ms·

But research, development, and marketing cost.

• Symmetry 8y ago
  IIRC most of the money spent on the development of a successful drug comes from the phase 3 clinical trial. R&D does make up a lot of a drug company's budget but that's because you do the R&D for the 10 drugs you start with, not just the 1 that makes it to market.
  • Scoundreller 8y ago
    It should be a joke for a generic drug company to take generic S-Ketamine and put it in another insufflation device and show bio equivalency. You don’t patent indications.
    • Symmetry 8y ago
      I don't think it's a joke that they could patent their special version of ketamine, I think it's a joke that despite the fact that we've been using ketatmine for generations and despite the fact that it's anti-depressant qualities are well attested to in the literature this brand of s-ketamine is the only one doctors are allowed to use. And there's research[1] showing that most of racemic ketamine's effect is from the r-ketamine, not the s-ketamine. [1]https://www.sciencedirect.com/science/article/pii/S0091305713003328?via%3Dihub https://www.sciencedirect.com/science/article/pii/S009130571...
      • Scoundreller 8y ago
        There’s no way they were the first to synthesize the S énantiomor. Usually doctors can still prescribe the compounded forms as long as they’re not duplicating something commercially available.
    • refurb 8y ago
      You don’t patent them, but you do get exclusivity with the FDA approval. FDA won’t approve another drug for 3-7 years.